Board certified in internal medicine and hematology, Dr. Jamie Stratton specializes in caring for patients with breast cancer, and benign and malignant blood disorders.
After completing her fellowship training in hematology and medical oncology at Yale Cancer Center, Dr. Stratton joined Stamford Health. She strives to help her patients and their families get through difficult times and develops long-term relationships with each person in her care.
Dr. Stratton helps her patients receive the information they need without feeling overwhelmed. She provides caring support, working with each of her patients to choose the treatments that are right for them.
Dr. Stratton also helps shape the future of cancer treatment, both as an assistant clinical professor at Columbia University School of Physicians and Surgeons and as a researcher at Bennett Cancer Center. She participates in the clinical trial program at the cancer center, giving her patients access to advanced trials and treatments that aren’t widely available.
Sondhi, D., Hackett, N., Peterson, D., Stratton, J., Baad, M., Travis, K., Wilson, J. and Crystal, R. (2007). Enhanced Survival of the LINCL Mouse Following CLN2 Gene Transfer Using the rh.10 Rhesus Macaque-derived Adeno-associated Virus Vector. Molecular Therapy. 15: 481-491.
Hackett, N., Redmond, D., Sondhi, D., Giannaris, E., Vassallo, E., Stratton, J., Qui, J., Kaminsky, S., Lesser, M., Fisch, G., Rouselle, S. and Crystal, R. Safety of Direct Administration of AAV2(CU)hCLN2, a Candidate for the Central Nervous System Manifestations of Late Infantile Neuronal Ceroid Lipofuscinosis, to the Brain of Rats and Nonhuman Primates (2005). Human Gene Therapy. 12: 1484-1503.